Gamco Investors INC. ET AL raised its stake in Kindred Healthcare, Inc. (NYSE:KND) by 57.0% during the second quarter, according to its most recent filing with the SEC. The fund owned 431,746 shares of the health services provider’s stock after buying an additional 156,700 shares during the period. Gamco Investors INC. ET AL owned 0.50% of Kindred Healthcare worth $5,030,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the company. BlackRock Inc. boosted its stake in Kindred Healthcare by 41,968.4% in the first quarter. BlackRock Inc. now owns 10,779,191 shares of the health services provider’s stock valued at $90,006,000 after buying an additional 10,753,568 shares during the last quarter. Wellington Management Group LLP boosted its stake in Kindred Healthcare by 40.9% in the first quarter. Wellington Management Group LLP now owns 7,945,247 shares of the health services provider’s stock valued at $66,342,000 after buying an additional 2,307,814 shares during the last quarter. Point72 Asset Management L.P. boosted its stake in Kindred Healthcare by 303.1% in the first quarter. Point72 Asset Management L.P. now owns 1,734,899 shares of the health services provider’s stock valued at $14,486,000 after buying an additional 1,304,499 shares during the last quarter. Norges Bank acquired a new stake in Kindred Healthcare during the fourth quarter valued at about $8,342,000. Finally, Bogle Investment Management L P DE acquired a new stake in Kindred Healthcare during the first quarter valued at about $3,085,000. 89.79% of the stock is currently owned by institutional investors.

Shares of Kindred Healthcare, Inc. (KND) opened at 7.75 on Thursday. Kindred Healthcare, Inc. has a one year low of $5.65 and a one year high of $11.90. The firm has a 50-day moving average of $9.41 and a 200 day moving average of $9.25. The stock’s market capitalization is $674.40 million.

Kindred Healthcare (NYSE:KND) last announced its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The business’s quarterly revenue was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.38 earnings per share. On average, equities research analysts predict that Kindred Healthcare, Inc. will post $0.53 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Kindred Healthcare, Inc. (KND) Stake Increased by Gamco Investors INC. ET AL” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/24/kindred-healthcare-inc-knd-stake-increased-by-gamco-investors-inc-et-al.html.

Several analysts recently issued reports on KND shares. Zacks Investment Research raised Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a research note on Wednesday, May 3rd. Royal Bank Of Canada reissued a “hold” rating and issued a $10.00 target price on shares of Kindred Healthcare in a research note on Monday, May 15th. Barclays PLC reissued a “buy” rating and issued a $13.00 target price (up from $11.00) on shares of Kindred Healthcare in a research note on Sunday, May 7th. BidaskClub cut Kindred Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Finally, Deutsche Bank AG cut their target price on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, August 7th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $9.94.

About Kindred Healthcare

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Want to see what other hedge funds are holding KND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kindred Healthcare, Inc. (NYSE:KND).

Institutional Ownership by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.